What is going on here?
The healthcare industry is bracing for a surge in IPOs and mergers by 2025, according to a Jefferies report, highlighting geopolitical tensions as the biggest risk.
What does this mean?
Jefferies' annual survey of nearly 500 senior medical professionals shows a positive outlook for IPOs and mergers in 2025. This optimism is supported by big deals such as Johnson & Johnson's $13.1 billion acquisition of Shockwave Medical and KKR's investment in Cotiviti. However, 40% of executives cite geopolitical tensions as the biggest risk, overshadowed by concerns about funding. Still, 72% expect M&A activity to increase, particularly in Europe, while the US remains the primary market. Furthermore, nearly two-thirds expect an increase in healthcare IPOs, suggesting a boost in equity capital markets.
Why should we care?
For the market: A prescription for growth.
Despite geopolitical risks, the healthcare sector is expected to grow due to significant M&A activity in Europe and an expected improvement in the Chinese market. Healthcare IPOs are expected to increase as private equity investors seek opportunities in the sector, indicating a strong equity capital market.
The big picture: A healthy outlook for the future.
Global healthcare trends are evolving and the outlook for the healthcare index is positive, with a rise in the FTSE 100 predicted by 2025. Positive market sentiment and year-end investment highlight strong growth in the sector driven by innovations like Novo Nordisk's Wegovy in weight loss drugs.
